1. Home
  2. TRU vs ICLR Comparison

TRU vs ICLR Comparison

Compare TRU & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRU
  • ICLR
  • Stock Information
  • Founded
  • TRU 1968
  • ICLR 1990
  • Country
  • TRU United States
  • ICLR Ireland
  • Employees
  • TRU N/A
  • ICLR N/A
  • Industry
  • TRU Finance: Consumer Services
  • ICLR Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • TRU Finance
  • ICLR Health Care
  • Exchange
  • TRU Nasdaq
  • ICLR Nasdaq
  • Market Cap
  • TRU 16.6B
  • ICLR 13.7B
  • IPO Year
  • TRU 2015
  • ICLR 1998
  • Fundamental
  • Price
  • TRU $76.32
  • ICLR $186.17
  • Analyst Decision
  • TRU Buy
  • ICLR Buy
  • Analyst Count
  • TRU 13
  • ICLR 15
  • Target Price
  • TRU $111.67
  • ICLR $210.64
  • AVG Volume (30 Days)
  • TRU 5.6M
  • ICLR 1.0M
  • Earning Date
  • TRU 10-23-2025
  • ICLR 10-22-2025
  • Dividend Yield
  • TRU 0.60%
  • ICLR N/A
  • EPS Growth
  • TRU N/A
  • ICLR 13.11
  • EPS
  • TRU 1.99
  • ICLR 9.73
  • Revenue
  • TRU $4,357,300,000.00
  • ICLR $8,089,820,000.00
  • Revenue This Year
  • TRU $7.99
  • ICLR N/A
  • Revenue Next Year
  • TRU $8.76
  • ICLR $1.42
  • P/E Ratio
  • TRU $38.38
  • ICLR $19.56
  • Revenue Growth
  • TRU 9.34
  • ICLR N/A
  • 52 Week Low
  • TRU $66.38
  • ICLR $125.10
  • 52 Week High
  • TRU $113.17
  • ICLR $303.69
  • Technical
  • Relative Strength Index (RSI)
  • TRU 33.06
  • ICLR 59.53
  • Support Level
  • TRU $70.20
  • ICLR $161.70
  • Resistance Level
  • TRU $77.79
  • ICLR $197.05
  • Average True Range (ATR)
  • TRU 2.96
  • ICLR 6.49
  • MACD
  • TRU -1.25
  • ICLR 2.00
  • Stochastic Oscillator
  • TRU 26.59
  • ICLR 70.56

About TRU TransUnion

TransUnion is one of the three leading credit bureaus in the United States, providing the consumer information that is the basis for granting credit. The company also provides fraud detection, marketing, and analytical services. TransUnion operates in over 30 countries. About 20%-25% of its revenue comes from international markets.

About ICLR ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Share on Social Networks: